Your browser doesn't support javascript.
loading
UFT and mitomycin plus tamoxifen for stage II, ER-positive breast cancer. Hokkaido ACETBC Study Group.
Hata, Y; Uchino, J; Asaishi, K; Kubo, Y; Mito, M; Tanabe, T; Ogita, M; Hirata, K.
Affiliation
  • Hata Y; Sapporo Social Insurance General Hospital, Japan.
Oncology (Williston Park) ; 13(7 Suppl 3): 91-5, 1999 Jul.
Article in En | MEDLINE | ID: mdl-10442372
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Receptors, Estrogen / Mitomycins Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Oncology (Williston Park) Journal subject: NEOPLASIAS Year: 1999 Document type: Article Affiliation country: Japan Country of publication: United States
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Receptors, Estrogen / Mitomycins Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Oncology (Williston Park) Journal subject: NEOPLASIAS Year: 1999 Document type: Article Affiliation country: Japan Country of publication: United States